Theratechnologies Inc (THTX) Stock: What Does the Chart Say Friday?

Theratechnologies Inc (THTX) stock is lower by 15.79% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Theratechnologies Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on THTX!

See Full THTX Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With THTX Stock Today?

Theratechnologies Inc (THTX) stock is trading at $1.12 as of 10:13 AM on Friday, Nov 10, a rise of $0.01, or 0.9% from the previous closing price of $1.11. The stock has traded between $1.10 and $1.16 so far today. Volume today is below average. So far 21,507 shares have traded compared to average volume of 238,245 shares. To screen for more stocks like Theratechnologies Inc click here.

More About Theratechnologies Inc

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. Click Here to get the full Stock Report for Theratechnologies Inc stock.